title: Multicenter italian experience in liver transplantation for hepatocellular carcinoma in HIV-infected patients.
abstract: BACKGROUND
  The aim of our work is to assess the clinical outcomes of liver transplantation (LT) for hepatocellular carcinoma (HCC) in HIV-coinfected patients. This is a multicenter study involving three Italian transplant centers in northern Italy: University of Modena, University of Bologna, and University of Udine.
  
  
  METHODS
  We compared 30 HIV-positive patients affected by HCC who underwent LT with 125 HIV-uninfected patients who received the same treatment from September 2004 to June 2009. At listing, there were no differences between HIV-infected and -uninfected patients regarding HCC features. Patients outside the University of California, San Francisco criteria (UCSF) were considered eligible for LT if a down-staging program permitted a reduction of tumor burden.
  
  
  RESULTS
  HIV-infected patients were younger, they were more frequently anti-HCV positive, and a higher number of HIV-infected patients presented a coinfection HBV-HCV. Pre-LT treatments (liver resection and or locoregional treatments) were similar between the two groups. Histological characteristics of the tumor were similar in patients with and without HIV infection. No differences were observed in terms of overall survival and HCC recurrence rates.
  
  
  CONCLUSIONS
  LT for HCC is a feasible procedure and the presence of HIV does not particularly affect the post-LT outcome.
authors.affiliation: Liver and Multivisceral Transplant Center, University of Modena and Reggio Emilia, Modena, Italy. f.diben@virgilio.it
authors.forename: Fabrizio
authors.initials: F
authors.lastname: Di Benedetto
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Tarantino
authors.forename: Giorgio
authors.initials: G
authors.lastname: Ercolani
authors.forename: Umberto
authors.initials: U
authors.lastname: Baccarani
authors.forename: Roberto
authors.initials: R
authors.lastname: Montalti
authors.forename: Nicola
authors.initials: N
authors.lastname: De Ruvo
authors.forename: Massimiliano
authors.initials: M
authors.lastname: Berretta
authors.forename: Gian Luigi
authors.initials: GL
authors.lastname: Adani
authors.forename: Matteo
authors.initials: M
authors.lastname: Zanello
authors.forename: Marcello
authors.initials: M
authors.lastname: Tavio
authors.forename: Nicola
authors.initials: N
authors.lastname: Cautero
authors.forename: Umberto
authors.initials: U
authors.lastname: Tirelli
authors.forename: Antonio D
authors.initials: AD
authors.lastname: Pinna
authors.forename: Giorgio E
authors.initials: GE
authors.lastname: Gerunda
authors.forename: Giovanni
authors.initials: G
authors.lastname: Guaraldi
mesh_terms: D000328:Adult; D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000150:complications / Q000473:pathology / Q000628:therapy* / Q000821:virology; D005260:Female; D005500:Follow-Up Studies; D015658:HIV Infections / Q000150:complications / Q000473:pathology / Q000628:therapy* / Q000821:virology; D015497:HIV-1 / Q000472:pathogenicity; D006801:Humans; D007558:Italy; D008113:Liver Neoplasms / Q000150:complications / Q000473:pathology / Q000628:therapy* / Q000821:virology; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000473:pathology; D015996:Survival Rate; D016896:Treatment Outcome
keywords: HCV; HIV; Hepatocellular carcinoma; Liver transplantation